Market Whales and Their Recent Bets on ALNY Options
Portfolio Pulse from Benzinga Insights
Investors with significant capital have shown interest in Alnylam Pharmaceuticals (NASDAQ:ALNY) options, with a mix of bullish and bearish sentiments. The options activity suggests a price range of $90 to $310. Analysts have varied ratings, with target prices ranging from $198 to $320.
August 30, 2024 | 8:17 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Alnylam Pharmaceuticals has seen unusual options activity, indicating mixed investor sentiment. Analysts have set varied price targets, reflecting uncertainty in the stock's short-term direction.
The unusual options activity in ALNY, with both bullish and bearish trades, suggests uncertainty among investors. Analysts' varied ratings and target prices further indicate mixed expectations for the stock's short-term performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100